HETERO LABS LIMITED
Location
Telangana
Founded
1989-03-10
Website
Risk Signals
265 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about HETERO LABS LIMITED
Live alerts from global media, monitored by Business Radar
2025-03-27 (nasdaq.com)
Rigel Pharma Settles Tavalisse Patent Litigation With Annora Pharma |
(RTTNews) - Rigel Pharmaceuticals, Inc. (RIGL) Thursday announced that it has entered into a settlement agreement with Annora Pharma Private Ltd., Hetero Labs Ltd., and Hetero USA, Inc. resolving patent litigation related to Rigel's product Tavalisse (fostamatinib disodium hexahy
Read more
2023-03-02 (bloomberglaw.com)
Catalyst Sues to Block Three Copies of Firdapse, Its Cash Cow
Catalyst Pharmaceuticals Inc. alleges in three new lawsuits that copies of Firdapse proposed by Teva Pharmaceutical Industries Ltd., Lupin Ltd., and Hetero Labs Ltd. infringe six patents it licenses from Serb SA for the rare autoimmune disorder treatment, its flagship drug.
Read more